Research ArticleOriginal Article
Open Access

Low oxytocin and melatonin levels and their possible role in the diagnosis and prognosis in Iraqi autistic children

Haidar A. Abdulamir, Omar F. Abdul-Rasheed and Emad A. Abdulghani
Saudi Medical Journal January 2016, 37 (1) 29-36; DOI: https://doi.org/10.15537/smj.2016.1.13183

References

  1. ↵
    1. Brentani H,
    2. Paula CS,
    3. Bordini D,
    4. Rolim D,
    5. Sato F,
    6. Portolese J,
    7. et al.
    (2013) Autism spectrum disorders: an overview on diagnosis and treatment. Rev Bras Psiquiatr 35(Suppl 1):S62–S72.
    OpenUrl
  2. ↵
    1. Rogers SJ
    (2009) What are infant siblings teaching us about autism in infancy? Autism Res 2:125–137.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Ruggeri B,
    2. Sarkans U,
    3. Schumann G,
    4. Persico AM
    (2014) Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology (Berl) 231:1201–1216.
    OpenUrl
  4. ↵
    1. Husarova V,
    2. Lakatosova S,
    3. Pivovarciova A,
    4. Bakos J,
    5. Durdiakova J,
    6. Kubranska A,
    7. et al.
    (2013) Brief report: Plasma oxytocin is lower in children with Asperger syndrome and associated with autistic trait attention to detail. Open Journal of Psychiatry 3:399–402.
    OpenUrl
  5. ↵
    1. Carson DS,
    2. Garner JP,
    3. Hyde SA,
    4. Libove RA,
    5. Berquist SW,
    6. Hornbeak KB,
    7. et al.
    (2015) Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism. PLoS One 10:e0132224.
    OpenUrl
  6. ↵
    1. de Faria Poloni J,
    2. Feltes BC,
    3. Bonatto D
    (2011) Melatonin as a central molecule connecting neural development and calcium signaling. Funct Integr Genomics 11:383–388.
    OpenUrlPubMed
  7. ↵
    1. Carrillo-Vico A,
    2. Lardone PJ,
    3. Alvarez-Sánchez N,
    4. Rodríguez-Rodríguez A,
    5. Guerrero JM
    (2013) Melatonin: buffering the immune system. Int J Mol Sci 14:8638–8683.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Tordjman S,
    2. Anderson GM,
    3. Bellissant E,
    4. Botbol M,
    5. Charbuy H,
    6. Camus F,
    7. et al.
    (2012) Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology 37:1990–1997.
    OpenUrl
  9. ↵
    1. Hammock E,
    2. Veenstra-VanderWeele J,
    3. Yan Z,
    4. Kerr TM,
    5. Morris M,
    6. Anderson GM,
    7. et al.
    (2012) Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems. J Am Acad Child Adolesc Psychiatry 51:712–721.
    OpenUrlCrossRefPubMed
  10. ↵
    1. American Psychiatric Association
    (2013) Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Publishing, Washington (DC)), 5th ed.
  11. ↵
    1. Norman G
    (2010) Likert scales, levels of measurement and the “laws” of statistics. Adv Health Sci Educ Theory Pract 15:625–632.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Hajian-Tilaki K
    (2013) Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation. Caspian J Intern Med 4:627–635.
    OpenUrlPubMed
  13. ↵
    1. Hye A,
    2. Lynham S,
    3. Thambisetty M,
    4. Causevic M,
    5. Campbell J,
    6. Byers HL,
    7. et al.
    (2006) Proteome-based plasma biomarkers for Alzheimer’s disease. Brain 129:3042–3050.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    1. Alabdali A,
    2. Al-Ayadhi L,
    3. El-Ansary A
    (2014) Association of social and cognitive impairment and biomarkers in autism spectrum disorders. J Neuroinflammation 11:4.
    OpenUrl
  15. ↵
    1. Slattery DA,
    2. Neumann ID
    (2010) Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible Treatment. Pharmaceuticals (Basel) 3:702–724.
    OpenUrl
  16. ↵
    1. Matsuzaki M,
    2. Matsushita H,
    3. Tomizawa K,
    4. Matsui H
    (2012) Oxytocin: a therapeutic target for mental disorders. J Physiol Sci 62:441–444.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Cao Y,
    2. Wu R,
    3. Tai F,
    4. Zhang X,
    5. Yu P,
    6. An X,
    7. et al.
    (2014) Neonatal paternal deprivation impairs social recognition and alters levels of oxytocin and estrogen receptor a mRNA expression in the MeA and NAcc, and serum oxytocin in mandarin voles. Horm Behav 65:57–65.
    OpenUrl
  18. ↵
    1. Lukas M,
    2. Neumann ID
    (2013) Oxytocin and vasopressin in rodent behaviors related to social dysfunctions in autism spectrum disorders. Behav Brain Res 251:85–94.
    OpenUrlCrossRefPubMed
  19. ↵
    1. Cochran DM,
    2. Fallon D,
    3. Hill M,
    4. Frazier JA
    (2013) The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harv Rev Psychiatry 21:219–247.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. El-Masry N,
    2. Soliman A,
    3. Abdel Moety H
    (2010) Alterations of prolyl endopeptidase, oxytocin and vasopressin activity in the plasma of autistic children. Current Psychiatry 17:31–37.
    OpenUrl
  21. ↵
    1. Quattrocki E,
    2. Friston K
    (2014) Autism, oxytocin and interoception. Neurosci Biobehav Rev 47:410–430.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Hovey D,
    2. Zettergren A,
    3. Jonsson L,
    4. Melke J,
    5. Anckarsäter H,
    6. Lichtenstein P,
    7. et al.
    (2014) Associations between oxytocin-related genes and autistic-like traits. Soc Neurosci 9:378–386.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Talarowska M,
    2. Szemraj J,
    3. Zajączkowska M,
    4. Gałecki P
    (2014) ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder. Med Sci Monit 20:905–912.
    OpenUrl
  24. ↵
    1. Kripke DF,
    2. Nievergelt CM,
    3. Tranah GJ,
    4. Murray SS,
    5. McCarthy MJ,
    6. Rex KM,
    7. et al.
    (2011) Polymorphisms in melatonin synthesis pathways: possible influences on depression. J Circadian Rhythms 9:8.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Marazziti D,
    2. Baroni S,
    3. Giannaccini G,
    4. Betti L,
    5. Massimetti G,
    6. Carmassi C,
    7. et al.
    (2012) A link between oxytocin and serotonin in humans: Supporting evidence from peripheral markers. Eur Neuropsychopharmacol 22:578–583.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Roszczyk M,
    2. Juszczak M
    (2014) Forskolin-stimulated vasopressin and oxytocin release from the rat hypothalamo-neurohypophysial system in vitro is inhibited by melatonin. Endokrynol Pol 65:125–131.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section